84 results
8-K
EX-2.2
ORTX
Orchard Therapeutics plc
24 Jan 24
Termination of a Material Definitive Agreement
4:17pm
successor Rights Agent who shall be a stock transfer agent of national reputation in the US or the corporate trust department of an international … . or the corporate trust department of an international commercial bank.
(e) The Rights Agent will cooperate with Purchaser and any successor Rights Agent
DEFA14A
ORTX
Orchard Therapeutics plc
8 Dec 23
Additional proxy soliciting materials
4:39pm
or by contacting Orchard’s Investor Relations Department at investors@orchard-tx.com.
Participants in the Solicitation
Orchard and certain of its directors
8-K
ORTX
Orchard Therapeutics plc
8 Dec 23
Other Events
4:37pm
at ir.orchard-tx.com or by contacting Orchard’s Investor Relations Department at investors@orchard-tx.com.
Participants in the Solicitation
Orchard and certain
DEFA14A
ORTX
Orchard Therapeutics plc
30 Nov 23
Additional proxy soliciting materials
4:13pm
Relations Department at investors@orchard-tx.com.
Participants in the Solicitation
Orchard and certain of its directors and executive officers may
8-K
ORTX
Orchard Therapeutics plc
30 Nov 23
Orchard Therapeutics Receives U.S. FDA Fast Track Designation for OTL-203 in MPS-IH
4:06pm
at ir.orchard-tx.com or by contacting Orchard’s Investor Relations Department at investors@orchard-tx.com.
Participants in the Solicitation
Orchard and certain
DEFA14A
tk4p ynescbuiytwej3
21 Nov 23
Additional proxy soliciting materials
7:53am
8-K
5mdfwp2avtflcn
21 Nov 23
Other Events
7:51am
DEFM14A
onh20sjj
16 Nov 23
Proxy related to merger
4:45pm
8-K
u7rukkzoyr6do7li ce
13 Nov 23
Orchard Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Business Accomplishments
7:05am
8-K
EX-99.1
ud752t0yz825efa3n
13 Nov 23
Orchard Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Business Accomplishments
7:05am
PREM14A
y223u aljf4ub5ti1j9
3 Nov 23
Preliminary proxy related to merger
5:11pm
DEFA14A
4se8077dbhftwuvcyg
17 Oct 23
Additional proxy soliciting materials
4:32pm
DEFA14C
0elg6jl94r4ht
5 Oct 23
Additional information
5:26pm
DEFA14C
k3r rsxwdct5
5 Oct 23
Additional information
4:48pm
DEFA14C
14mv114lbdaxt8d9
5 Oct 23
Additional information
4:45pm
DEFA14C
66h7nf3mp0exu
5 Oct 23
Additional information
4:43pm
DEFA14C
xdu9380 jubbj
5 Oct 23
Additional information
4:40pm
DEFA14A
grtpden
5 Oct 23
Additional proxy soliciting materials
9:07am
8-K
EX-2.1
89ug4bfaey1po
5 Oct 23
Kyowa Kirin to Acquire Orchard Therapeutics
9:05am